<SEC-DOCUMENT>0001410578-19-000263.txt : 20200226
<SEC-HEADER>0001410578-19-000263.hdr.sgml : 20200226
<ACCEPTANCE-DATETIME>20190524165445
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001410578-19-000263
CONFORMED SUBMISSION TYPE:	DRSLTR
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
		CENTRAL INDEX KEY:			0001477845
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262540421
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRSLTR

	BUSINESS ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312
		BUSINESS PHONE:		610-727-3913

	MAIL ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QR Pharma, Inc.
		DATE OF NAME CHANGE:	20091202
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRSLTR
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="152" height="77" src="g96354bci001.jpg"></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">May&nbsp;24, 2019</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">CONFIDENTIAL SUBMISSION</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities and Exchange Commission<br> Division of Corporation Finance<br> Office of Healthcare&nbsp;&amp; Insurance<br> Washington, D.C.&#160; 20549</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.66%;">
<p style="margin:0in 0in .0001pt 46.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Re:</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annovis Bio,&nbsp;Inc. (the &#147;Company&#148;)</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.66%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Draft Registration Statement on Form&nbsp;S-1</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.66%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Submitted May&nbsp;15, 2019</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.66%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CIK No.&nbsp;0001477845</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company submits the following response to the staff&#146;s comment letter dated May&nbsp;20, 2019 (the &#147;Comment Letter&#148;) relating to the Company&#146;s Draft Registration Statement on Form&nbsp;S-1, submitted May&nbsp;15, 2019 (the &#147;Draft Registration Statement&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have reproduced the text of the staff&#146;s comment in bold-face type followed by the Company&#146;s response.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Draft Registration Statement on Form&nbsp;S-1 submitted May&nbsp;15, 2019</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Index to Financial Statements, page&nbsp;F-1</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>We note the financial statements included in the draft registration statement are as of a date 135 days or more before the date the document was submitted.&#160; Based on your representation that at the time of the contemplated offering, you will be required to present the March&nbsp;31, 2019 interim financial statements in the document, please update your disclosure to include these financial statements.&#160; We will not perform a detailed examination of the draft registration statement until you do so.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">COMPANY RESPONSE:&#160; On March&nbsp;24, 2019, the Company submitted confidential draft #2 of the Draft Registration Statement to include the March&nbsp;31, 2019 financial statements in the document.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105536\19-9635-4\task9372587\9635-4-bc.htm',USER='105536',CD='May 24 19:43 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you or any member of the staff has any further comments or questions regarding this response, please contact the Company&#146;s counsel, John W. Kauffman,&nbsp;Esq. of Duane Morris LLP at (215) 979-1227 or jwkauffman@duanemorris.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sincerely,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANNOVIS BIO,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jeffrey McGroarty,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Financial Officer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_193620_7034"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\105536\19-9635-4\task9372587\9635-4-bc.htm',USER='105536',CD='May 24 19:43 2019' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g96354bci001.jpg
<TEXT>
begin 644 g96354bci001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !- )@# 2(  A$! Q$!_\0
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M-)-@&R=N,\-_WUS0![%12"O+X_B3)H7CC5-,U=C+IWVI@DQ^];C XQW7/Y4
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*BBF< 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
